Clinical Trials in Denver

Showing 10761-10780 of 15,604 trials

Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers

NCT02098369

About 1 million individuals in the US have a prescription for supplemental oxygen (O2). Using O2 can prolong life and increase quality of life. Patients often do not use their oxygen as prescribed, which means that they are not benefiting as much as they could be from this therapy. The purpose of this study is to evaluate whether a PEer-Led O2 Infoline for patients and CAregivers (PELICAN) will increase adherence to supplemental oxygen prescription and improve health in patients with chronic obstructive pulmonary disease (COPD).

Chronic Obstructive Pulmonary Disease (COPD)

University of Illinois at Chicago444 participantsStarted Apr 2015

Lake Forest, California, United States • Torrance, California, United States • Denver, Colorado, United States +3 more locations

COMPLETEDPhase 4< 1 mile

SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.

NCT01475721

The purpose of this study is to assess whether the risk of serious asthma-related events (asthma-related hospitalizations, endotracheal intubations, and deaths) in adolescents and adults (12 years of age and older) taking inhaled fluticasone propionate/salmeterol combination is the same as those taking inhaled fluticasone propionate alone. ADVAIR™ and FLOVENT™ are trademarks of the GlaxoSmithKline Group of Companies.

Asthma

GlaxoSmithKline11,751 participantsStarted Nov 2011

Athens, Alabama, United States • Birmingham, Alabama, United States • Birmingham, Alabama, United States +805 more locations

Comparative Effectiveness of a Peer-led O2 Infoline for Patients and Caregivers

SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.

Find Trials by Condition in Denver

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol 100/25 Microgram (mcg) Inhalation Powder, Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and Fluticasone Propionate 250 mcg Inhalation Powder in Adults and Adolescents With Persistent Asthma

6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old

Ferric Citrate for the Transition From CKD Stage 4/5 to CKD Stage 5D

Study of Dupilumab Auto-injector Device When Used by Patients With Atopic Dermatitis

Certolizumab Pegol for the Treatment of Patients With Active Rheumatoid Arthritis

Efficacy of Voice Treatment for Parkinson's Disease

Optimized Sleep After Brain Injury: Sleep Hygiene Intervention After Traumatic Brain Injury

A follow-on Safety Study of CDP870 in Subjects With Crohn's Disease (CD) Who Have Completed a 26-week Double Blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425]

A 24-week Evaluation of GSK573719/Vilanterol (62.5/25mcg) and Components in COPD

Study to Assess the Short- and Long-term Efficacy of Certolizumab Pegol Plus Methotrexate Compared to Adalimumab Plus Methotrexate in Subjects With Moderate to Severe Rheumatoid Arthritis (RA) Inadequately Responding to Methotrexate

Presatovir in Hematopoietic Cell Transplant Recipients With Respiratory Syncytial Virus Infection of the Upper Respiratory Tract

Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay

Immunogenicity & Safety of Hepatitis A Vaccine Co-admin With a Measles/Mumps/Rubella & a Varicella Vaccine in Children

Assessing the Use of Certolizumab Pegol in Adult Subjects With Rheumatoid Arthritis on the Antibody Response When Receiving Influenza Virus and Pneumococcal Vaccines

Evaluation of Efficacy and Safety of E004 in Children With Asthma

Shared Decision Making in the Emergency Department: Chest Pain Choice Trial

A Study to Evaluate the Efficacy and Safety of Oral VT-1161 in Patients With Moderate - Severe Interdigital Tinea Pedis

Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma